288 related articles for article (PubMed ID: 32016321)
1. Fabry Disease With Concomitant Lewy Body Disease.
Del Tredici K; Ludolph AC; Feldengut S; Jacob C; Reichmann H; Bohl JR; Braak H
J Neuropathol Exp Neurol; 2020 Apr; 79(4):378-392. PubMed ID: 32016321
[TBL] [Abstract][Full Text] [Related]
2. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
3. Formation and development of Lewy pathology: a critical update.
Jellinger KA
J Neurol; 2009 Aug; 256 Suppl 3():270-9. PubMed ID: 19711116
[TBL] [Abstract][Full Text] [Related]
4. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.
Marui W; Iseki E; Nakai T; Miura S; Kato M; Uéda K; Kosaka K
J Neurol Sci; 2002 Mar; 195(2):153-9. PubMed ID: 11897247
[TBL] [Abstract][Full Text] [Related]
5. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
Uchihara T; Giasson BI
Acta Neuropathol; 2016 Jan; 131(1):49-73. PubMed ID: 26446103
[TBL] [Abstract][Full Text] [Related]
6. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.
Jellinger KA
Mov Disord; 2012 Jan; 27(1):8-30. PubMed ID: 22081500
[TBL] [Abstract][Full Text] [Related]
7. Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders.
Goker-Alpan O; Stubblefield BK; Giasson BI; Sidransky E
Acta Neuropathol; 2010 Nov; 120(5):641-9. PubMed ID: 20838799
[TBL] [Abstract][Full Text] [Related]
8. Regional Overlap of Pathologies in Lewy Body Disorders.
Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
[TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease.
Ito S; Takao M; Hatsuta H; Kanemaru K; Arai T; Saito Y; Fukayama M; Murayama S
Int J Clin Exp Pathol; 2014; 7(4):1714-23. PubMed ID: 24817969
[TBL] [Abstract][Full Text] [Related]
10. Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia.
Uchikado H; Iseki E; Tsuchiya K; Togo T; Katsuse O; Uéda K; Kato M; Kosaka K
Clin Neuropathol; 2002; 21(6):269-77. PubMed ID: 12489676
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease.
Zhou W; Milder JB; Freed CR
J Biol Chem; 2008 Apr; 283(15):9863-70. PubMed ID: 18238775
[TBL] [Abstract][Full Text] [Related]
12. The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.
Seidel K; Mahlke J; Siswanto S; Krüger R; Heinsen H; Auburger G; Bouzrou M; Grinberg LT; Wicht H; Korf HW; den Dunnen W; Rüb U
Brain Pathol; 2015 Mar; 25(2):121-35. PubMed ID: 24995389
[TBL] [Abstract][Full Text] [Related]
13. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
Jellinger KA
Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
[TBL] [Abstract][Full Text] [Related]
14. Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology.
Lewis KA; Su Y; Jou O; Ritchie C; Foong C; Hynan LS; White CL; Thomas PJ; Hatanpaa KJ
Am J Pathol; 2010 Dec; 177(6):3037-50. PubMed ID: 21056999
[TBL] [Abstract][Full Text] [Related]
15. Pathological roles of α-synuclein in neurological disorders.
Vekrellis K; Xilouri M; Emmanouilidou E; Rideout HJ; Stefanis L
Lancet Neurol; 2011 Nov; 10(11):1015-25. PubMed ID: 22014436
[TBL] [Abstract][Full Text] [Related]
16. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
[TBL] [Abstract][Full Text] [Related]
17. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.
Yamaguchi K; Cochran EJ; Murrell JR; Polymeropoulos MH; Shannon KM; Crowther RA; Goedert M; Ghetti B
Acta Neuropathol; 2005 Sep; 110(3):298-305. PubMed ID: 15981014
[TBL] [Abstract][Full Text] [Related]
18. Glial involvement in diffuse Lewy body disease.
Terada S; Ishizu H; Yokota O; Tsuchiya K; Nakashima H; Ishihara T; Fujita D; Uéda K; Ikeda K; Kuroda S
Acta Neuropathol; 2003 Feb; 105(2):163-9. PubMed ID: 12536227
[TBL] [Abstract][Full Text] [Related]
19. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
[TBL] [Abstract][Full Text] [Related]
20. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]